Last update 11 Mar 2026

KNT-0916

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
KNT-0916
Target
FGFR2
Action
antagonists
Mechanism
FGFR2 antagonists(Fibroblast growth factor receptor 2 antagonists)
Therapeutic Areas
Neoplasms
Active Indication
Solid tumorFGFR2 Mutation Solid Tumors
Inactive Indication-
Originator Organization
KinoTeck Therapeutics Co., Ltd
Active Organization
KinoTeck Therapeutics Co., Ltd
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with KNT-0916
NCT06800196
/ Not yet recruitingPhase 1
A Phase I, Multicenter, Open-label Study to Evaluate the Safety, Pharmacokinetics, Preliminary Efficacy of KNT-0916 in Subjects with Unresectable or Metastatic Solid Tumors with FGFR2 Alterations
100 Clinical Results associated with KNT-0916
Login to view more data
100 Translational Medicine associated with KNT-0916
Login to view more data
100 Patents (Medical) associated with KNT-0916
Login to view more data
100 Deals associated with KNT-0916
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Solid tumorPhase 1-
KinoTeck Therapeutics Co., Ltd
31 Mar 2025
FGFR2 Mutation Solid TumorsPhase 1
China
KinoTeck Therapeutics Co., Ltd
26 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
CTR20250595 (NEWS)
ManualManual
Phase 1
FGFR2 Mutation Solid Tumors
FGFR2 Mutation | FGFR2 Fusion | FGFR2 Amplification
50
(Dose‑escalation 剂量递增阶段)
pqlewdfvko(rkkwbewnto) = qekfkfsucq rjbeuwpqlh (ifhbhxokwu )
View more
Positive
28 Nov 2025
(Dose‑expansion 剂量扩展阶段)
lnzlqoiyzd(oqblgavcyr) = tiuiyusqom awdcicyywf (qddzzjfksk )
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free